Patents by Inventor Heinrich Decker

Heinrich Decker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7939293
    Abstract: The invention relates to the production of carboxy-terminal (C-terminal) amidified peptides with C-terminal amidified lysin, in particular with the biological activity of GLP-1, the chemical and/or biotechnological precursors and intermediate products thereof. The invention also relates to a method for the production and use thereof for producing pharmaceutical products.
    Type: Grant
    Filed: November 18, 2005
    Date of Patent: May 10, 2011
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Paul Habermann, Heinrich Decker, Claus Lattemann, Oliver Maneg, Christophe Salagnad, Frank Zocher
  • Patent number: 7785826
    Abstract: The invention relates to a method for the enzymatic elimination of the N-acyl side chain from lipopeptides to form the corresponding nucleus, wherein the lipopeptide is prepared by fermentation, the lipopeptide being bound to the cells of the biomass, and the biomass is removed with the adhering lipopeptide, the biomass with the adhering lipopeptide is resuspended in an aqueous system, a suitable deacylase is added in dissolved or solid form to the suspension of the biomass, and the corresponding nucleus is formed, and the nucleus is optionally isolated and purified, wherein the lipopeptide obtained by fermentation is reacted after the end of the fermentation as cell-bound biomass without further purification directly with a deacylase, whereby the N-acyl chain linked via an amide linkage is eliminated.
    Type: Grant
    Filed: June 5, 2007
    Date of Patent: August 31, 2010
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Eberhard Ehlers, Heinrich Decker, Sebastian Rissom, Guido Seidel, Reiner Olliger
  • Publication number: 20090005299
    Abstract: The invention relates to the production of carboxy-terminal (C-terminal) amidified peptides with C-terminal amidified lysin, in particular with the biological activity of GLP-1, the chemical and/or biotechnological precursors and intermediate products thereof. The invention also relates to a method for the production and use thereof for producing pharmaceutical products.
    Type: Application
    Filed: November 18, 2005
    Publication date: January 1, 2009
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Paul Habermann, Heinrich Decker, Claus Lattemann, Oliver Maneg, Christophe Salagnad, Frank Zocher
  • Publication number: 20080076149
    Abstract: The invention relates to a method for the enzymatic elimination of the N-acyl side chain from lipopeptides to form the corresponding nucleus, wherein the lipopeptide is prepared by fermentation, the lipopeptide being bound to the cells of the biomass, and the biomass is removed with the adhering lipopeptide, the biomass with the adhering lipopeptide is resuspended in an aqueous system, a suitable deacylase is added in dissolved or solid form to the suspension of the biomass, and the corresponding nucleus is formed, and the nucleus is optionally isolated and purified, wherein the lipopeptide obtained by fermentation is reacted after the end of the fermentation as cell-bound biomass without further purification directly with a deacylase, whereby the N-acyl chain linked via an amide linkage is eliminated.
    Type: Application
    Filed: June 5, 2007
    Publication date: March 27, 2008
    Applicant: SANOFI-AVENTIS DEUTSCHLAND GMBH
    Inventors: Eberhard EHLERS, Heinrich DECKER, Sebastian RISSOM, Guido SEIDEL, Reiner OLLIGER
  • Patent number: 6825013
    Abstract: The invention relates to a recombinant DNA molecule which comprises genes for biosynthesizing acarbose and homologous pseudo-oligosaccharides; to oligonucleotide primers for the PCR amplification of the molecule; to proteins which can be obtained by expressing the genes located on a molecule; to vectors and host cells which comprise the above-mentioned DNA molecule; to proteins which are encoded by the DNA molecule; to proteins which are expressed by means of said vectors in said host cells; to processes for preparing acarbose by introducing the characterized genes into appropriate host organisms and/or eliminating these genes from the host organisms; to processes for completing the gene cluster of genes for biosynthesizing acarbose, to processes for isolating analogous gene clusters in organisms other than Streptomyces glaucescens GLA.
    Type: Grant
    Filed: August 7, 2001
    Date of Patent: November 30, 2004
    Assignee: Avantis Pharma Deutschland GmbH
    Inventor: Heinrich Decker
  • Patent number: 6642391
    Abstract: A compound named Amycomycin of the formula: is described, as well as its pharmaceutically acceptable salts and derivatives, in all their stereoisomeric and tautomeric forms. The compound is obtained by growing the microorganism Amycolatopsis species ST101170 (DSM 12216) and is useful as a pharmaceutical, particularly as an antibiotic.
    Type: Grant
    Filed: December 7, 2000
    Date of Patent: November 4, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Cordula Hopmann, Michael Kurz, Heinrich Decker, Dominique Le Beller, Jozsef Aszodi
  • Patent number: 6624143
    Abstract: The invention relates to a calcium salt of the compound of formula (II), where R1 is a straight-chain or branched, saturated or unsaturated aliphatic acyl radical having 8 to 22 carbon atoms, which can optionally be interrupted by or linked to one or more phenyl or cycloalkyl groups and optionally interrupted by oxygen. The invention also relates to a method for producing said calcium salt and to its use as a medicine.
    Type: Grant
    Filed: August 25, 2000
    Date of Patent: September 23, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Laszló Vértesy, Werner Aretz, Heinrich Decker, Eberhard Ehlers, Michael Kurz, Frank Rainer Schmidt
  • Publication number: 20020192793
    Abstract: The invention relates to a recombinant DNA molecule which comprises genes for biosynthesizing acarbose and homologous pseudo-oligosaccharides; to oligonucleotide primers for the PCR amplification of the molecule; to proteins which can be obtained by expressing the genes located on a molecule; to vectors and host cells which comprise the above-mentioned DNA molecule; to proteins which are encoded by the DNA molecule; to proteins which are expressed by means of said vectors in said host cells; to processes for preparing acarbose by introducing the characterized genes into appropriate host organisms and/or eliminating these genes from the host organisms; to processes for completing the gene cluster of genes for biosynthesizing acarbose, to processes for isolating analogous gene clusters in organisms other than Streptomyces glaucescens GLA.
    Type: Application
    Filed: August 7, 2001
    Publication date: December 19, 2002
    Inventor: Heinrich Decker
  • Patent number: 6306627
    Abstract: The invention relates to a recombinant DNA molecule which comprises genes for biosynthesizing acarbose and homologous pseudo-oligosaccharides; to oligonucleotide primers for the PCR amplification of the molecule; to proteins which can be obtained by expressing the genes located on a molecule; to vectors and host cells which comprise the above-mentioned DNA molecule; to proteins which are encoded by the DNA molecule; to proteins which are expressed by means of said vectors in said host cells; to processes for preparing acarbose by introducing the characterized genes into appropriate host organisms and/or eliminating these genes from the host organisms; to processes for completing the gene cluster of genes for biosynthesizing acarbose, to processes for isolating analogous gene clusters in organisms other than Streptomyces glaucescens GLA.
    Type: Grant
    Filed: July 29, 1998
    Date of Patent: October 23, 2001
    Assignee: Aventis Pharma Deutschland GmbH
    Inventor: Heinrich Decker
  • Publication number: 20010018450
    Abstract: A compound named Amycomycin of the formula: 1
    Type: Application
    Filed: December 7, 2000
    Publication date: August 30, 2001
    Inventors: Cordula Hopmann, Michael Kurz, Heinrich Decker, Dominique Le Beller, Jozsef Aszodi
  • Patent number: 5078190
    Abstract: A tire tread of a vehicular tire has, in a peripheral tire direction, a plurality of tread block rows that are separated from one another by wave-shaped longitudinal grooves arranged essentially in the peripheral tire direction. The individual tread blocks within each individual tread block row are separated form one another by transverse grooves, whereby the transverse grooves are arranged such that in a left tread half as well as in a right tread half the transverse grooves are aligned with one another. The groove center lines of the transverse grooves at the outer rims of the tire tread are slanted relative to a tire axis at an angle of 3.degree. to 15.degree.. The groove center lines of the transverse grooves of the center tread block rows are slanted relative to the tire axis at an angle of 15.degree. to 50.degree. whereby the transverse grooves create a design of transversely arranged elongated S-shaped grooves.
    Type: Grant
    Filed: December 28, 1990
    Date of Patent: January 7, 1992
    Assignee: Continental Aktiengesellschaft
    Inventors: Horst Wissbrock, Heinrich Decker, Helmut Gaus, Werner Knauf, Heinrich Huinink, Daniel Pfaff